Cannabis vaporisation: Understanding products, devices and risks
Drug and Alcohol Review · 2024-03 · 43 (3) · 732-745
DOI: 10.1111/dar.13800 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug and Alcohol Review, online erschienen am 20.12.2023. Verfasst von Caroline A MacCallum und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Cannabis, Hallucinogens. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Issues Vaporisation is a common method of cannabis administration. Inconsistent terminology and jargon regarding vaporisation has led to confusion. The increasing public interest and access to cannabis, combined with possible safety concerns associated with certain cannabis vaping products, warrants improved consumer and public and health care professional knowledge. Approach To improve this knowledge, we conducted a review of the common terminology, regulatory status, products and device types related to cannabis vaporisation. Key Findings Cannabis vaporisation devices can be separated into nine types. While vaporisation reduces respiratory risks associated with cannabis combustion, not all vaping products and device types carry the same level of safety. Metered dose inhalers and dried product vaporisers present the lowest safety risk due to a lower risk of toxin exposure and the use of lower tetrahydrocannabinol potency products.
Implications
As both vaping and cannabis use increase in popularity, focusing on accurate health education will help facilitate health promotion to encourage lower risk use. The current lack of understanding on risk differences between types of cannabis vaporisation is a missed opportunity for harm reduction. Increased opportunities for public health and health care professional education on different cannabis vaporisation devices and associated risks are warranted. Improvements to health warning labelling may also be beneficial.
Conclusion
Not all cannabis vaporisation devices and products carry the same level of risk. A better understanding of risk differentiation is needed among consumers and health professionals. Continued research, policy development and health education can lead to safer cannabis vaporisation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
- Department of Public Health Science, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
- Faculty of Science, University of British Columbia, Vancouver, Canada.
- Six Degrees Medical, Vancouver, Canada.
- CommPharm Consulting, Barrie, Canada.
ORCID-Profile: Caroline A MacCallum
Zitieren
APA
MacCallum, C. A., Lo, L. A., Pistawka, C. A., Christiansen, A., & Boivin, M. (2024). Cannabis vaporisation: Understanding products, devices and risks. Drug and Alcohol Review, 43(3), 732-745. https://doi.org/10.1111/dar.13800
Vancouver
MacCallum CA, Lo LA, Pistawka CA, Christiansen A, Boivin M. Cannabis vaporisation: Understanding products, devices and risks. Drug and Alcohol Review. 2024;43(3):732-745. doi:10.1111/dar.13800
BibTeX
@article{MacCallum2024,
author = {MacCallum, Caroline A and Lo, Lindsay A and Pistawka, Carly A and Christiansen, April and Boivin, Michael},
title = {Cannabis vaporisation: Understanding products, devices and risks},
journal = {Drug and Alcohol Review},
year = {2024},
volume = {43},
number = {3},
pages = {732--745},
doi = {10.1111/dar.13800}
}
EUVIMED